Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UP-SPOUT: Upadacitinib in Active Psoriatic Arthritis
NCT06454188Phase 4Recruiting
- Sponsor
- CARE Arthritis
- Start
- Dec 2024
- Primary completion
- Sep 2028
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 4 trial of upadacitinib in psoriatic arthritis (PsA), axial spondyloarthritis (axSpA), sponsored by CARE Arthritis. Started Dec 2024; status: recruiting.
02
Drugs
upadacitinib
03
Conditions
psoriatic arthritis (PsA)axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT06454188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06454188.